Top compounds associated with response to CCDC183


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.005
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.096 0.005
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.099 0.005
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.099 0.005
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.005
mRNA EX-527 CTRPv2 pan-cancer AAC 0.11 0.005
Download CSV